Blueprint Medicines (BPMC) News Today → The world’s greatest investment (From Porter & Company) (Ad) Free BPMC Stock Alerts $86.82 -3.68 (-4.07%) (As of 03/18/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAmerican Century Companies Inc. Has $33.70 Million Stock Position in Blueprint Medicines Co. (NASDAQ:BPMC)marketbeat.com - March 19 at 4:50 AMShort Interest in Blueprint Medicines Co. (NASDAQ:BPMC) Grows By 11.0%americanbankingnews.com - March 19 at 3:06 AMInsider Selling: Blueprint Medicines Co. (NASDAQ:BPMC) Insider Sells 621 Shares of Stockinsidertrades.com - March 16 at 10:36 AMBPMC Apr 2024 90.000 putfinance.yahoo.com - March 16 at 12:53 AMBlueprint Medicines Corp's Chief Commercial Officer Sells Company Sharesfinance.yahoo.com - March 15 at 7:53 PMBPMC Apr 2024 45.000 putfinance.yahoo.com - March 15 at 9:52 AMWellington Management Group LLP Increases Stock Position in Blueprint Medicines Co. (NASDAQ:BPMC)marketbeat.com - March 15 at 6:43 AMHudson Bay Capital Management LP Increases Position in Blueprint Medicines Co. (NASDAQ:BPMC)marketbeat.com - March 14 at 7:25 AMBlueprint Medicines Co. (NASDAQ:BPMC) Insider L. Becker Hewes Sells 3,097 Shares of Stockamericanbankingnews.com - March 12 at 6:02 AMBlueprint Medicines Co. (NASDAQ:BPMC) EVP Tracey L. Mccain Sells 5,194 Sharesamericanbankingnews.com - March 12 at 5:16 AMBlueprint Medicines Co. (NASDAQ:BPMC) COO Christina Rossi Sells 6,070 Shares of Stockamericanbankingnews.com - March 12 at 5:16 AMBlueprint Medicines Co. (NASDAQ:BPMC) CFO Michael Landsittel Sells 5,003 Sharesamericanbankingnews.com - March 12 at 5:16 AMInsider Selling: Blueprint Medicines Co. (NASDAQ:BPMC) Insider Sells 3,097 Shares of Stockinsidertrades.com - March 12 at 4:58 AMBlueprint Medicines Co. (NASDAQ:BPMC) CEO Kate Haviland Sells 12,464 Shares of Stockamericanbankingnews.com - March 12 at 4:40 AML. Becker Hewes Sells 3,097 Shares of Blueprint Medicines Co. (NASDAQ:BPMC) Stockmarketbeat.com - March 11 at 7:33 PMPolar Capital Holdings Plc Boosts Stock Position in Blueprint Medicines Co. (NASDAQ:BPMC)marketbeat.com - March 11 at 1:50 PMBlueprint Medicines Co. (NASDAQ:BPMC) Receives Average Rating of "Moderate Buy" from Analystsamericanbankingnews.com - March 11 at 2:32 AMBlueprint Medicines Co. (NASDAQ:BPMC) Receives Consensus Recommendation of "Moderate Buy" from Analystsmarketbeat.com - March 11 at 2:32 AMAnalysts Set Expectations for Blueprint Medicines Co.'s Q1 2024 Earnings (NASDAQ:BPMC)marketbeat.com - March 7 at 6:55 AMBlueprint Medicines Co. (NASDAQ:BPMC) Insider Christopher K. Murray Sells 621 Sharesmarketbeat.com - March 6 at 1:31 PMEquities Analysts Offer Predictions for Blueprint Medicines Co.'s FY2026 Earnings (NASDAQ:BPMC)marketbeat.com - March 6 at 8:32 AMBPMC Apr 2024 120.000 callfinance.yahoo.com - March 4 at 2:50 PMBPMC Dec 2024 115.000 callfinance.yahoo.com - March 4 at 9:50 AMBPMC Jun 2024 115.000 callfinance.yahoo.com - March 4 at 9:50 AMBPMC Mar 2024 100.000 putfinance.yahoo.com - March 3 at 10:32 PMBlueprint Medicines Co. (NASDAQ:BPMC) Insider Christopher K. Murray Sells 5,000 Sharesmarketbeat.com - March 1 at 3:41 PMBuy Rating Affirmed for Blueprint Medicines on Strong Ayvakit Clinical Performance and Promising Pipelinemarkets.businessinsider.com - February 26 at 1:25 PMBlueprint Medicines Receives Sell Rating Amidst Modest Polypharmacy Reduction and Negative Share Price Projectionsmarkets.businessinsider.com - February 26 at 1:25 PMBlueprint Medicines: Sell Rating Justified by Gavreto Divestiture and Strategic Shiftmarkets.businessinsider.com - February 26 at 8:24 AMBlueprint Medicines (NASDAQ:BPMC) Given "Buy" Rating at Needham & Company LLCmarketbeat.com - February 26 at 8:12 AMBlueprint Medicines (BPMC) Price Target Increased by 11.02% to 99.12msn.com - February 24 at 2:06 AMStifel Nicolaus Keeps Their Buy Rating on Blueprint Medicines (BPMC)markets.businessinsider.com - February 23 at 10:47 AMBlueprint Medicines Highlights AYVAKIT® (avapritinib) Long-Term Efficacy and Safety Data and Advances in Mast Cell Disease Research at 2024 AAAAI Annual Meetingfinance.yahoo.com - February 23 at 10:47 AMBlueprint Medicines Co. (NASDAQ:BPMC) Shares Sold by Charles Schwab Investment Management Inc.marketbeat.com - February 23 at 4:33 AMCHI Advisors LLC Makes New Investment in Blueprint Medicines Co. (NASDAQ:BPMC)marketbeat.com - February 22 at 1:39 PMBlueprint Medicines: Ayvakit Revenue Surge Fuels Optimism (Rating Upgrade)seekingalpha.com - February 20 at 12:17 PMBlueprint Medicines Co. (NASDAQ:BPMC) Shares Bought by Rafferty Asset Management LLCmarketbeat.com - February 18 at 7:28 AMBPMC Feb 2024 80.000 callfinance.yahoo.com - February 17 at 10:23 AMBlueprint Medicines Full Year 2023 Earnings: Beats Expectationsfinance.yahoo.com - February 17 at 10:23 AMBPMC Mar 2024 100.000 callfinance.yahoo.com - February 16 at 11:36 PMBlueprint Medicines: Strong Buy on Impressive Q4 Earnings and Promising Ayvakit Revenue Projectionsmarkets.businessinsider.com - February 16 at 6:36 PMHere's What Key Metrics Tell Us About Blueprint Medicines (BPMC) Q4 Earningsfinance.yahoo.com - February 16 at 6:36 PMBlueprint Medicines (NASDAQ:BPMC) Rating Reiterated by JMP Securitiesmarketbeat.com - February 16 at 3:50 PMBlueprint Medicines price target lowered by $8 at Wells Fargo, here's whyrealmoney.thestreet.com - February 16 at 1:36 PMSell Rating on Blueprint Medicines Amidst Concerns Over Long-Term Growth and Financial Outlookmarkets.businessinsider.com - February 16 at 1:36 PMBlueprint Medicines Corporation (NASDAQ:BPMC) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - February 16 at 1:36 PMBlueprint Medicines (NASDAQ:BPMC) Given New $65.00 Price Target at Citigroupmarketbeat.com - February 16 at 12:38 PMBlueprint Medicines Co. (NASDAQ:BPMC) Short Interest Up 5.3% in Januarymarketbeat.com - February 16 at 11:31 AMBlueprint Medicines (NASDAQ:BPMC) Hits New 12-Month High After Better-Than-Expected Earningsmarketbeat.com - February 16 at 10:32 AMBlueprint (BPMC) Q4 Earnings Beat, Stock Up as Ayvakit Shinesfinance.yahoo.com - February 16 at 8:35 AM Get Blueprint Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for BPMC and its competitors with MarketBeat's FREE daily newsletter. Email Address The world’s greatest investment (Ad)I believe this could change your life forever. I’m talking about transforming everything for you, financially. You see, a rare market anomaly has emerged that I believe is going to make some people very wealthy. Almost nobody in the mainstream media or Wall Street has connected the dots on what’s going on, but that ignorance won’t last for long. When they wake up to this situation, billions of dollars will flood in. Click here now to sign up BPMC Media Mentions By Week BPMC Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BPMC News Sentiment▼0.710.62▲Average Medical News Sentiment BPMC News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BPMC Articles This Week▼145▲BPMC Articles Average Week Get Blueprint Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for BPMC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: NUVL News Today MDGL News Today BBIO News Today BHVN News Today ALKS News Today ITCI News Today IONS News Today OGN News Today CYTK News Today VKTX News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BPMC) was last updated on 3/19/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial Metals8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)Paradigm PressAltcoin FRENZY Alert…Crypto 101 MediaThe AI Bottleneck No One is Talking AboutThe Bull ReportThe world’s greatest investmentPorter & CompanyMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Blueprint Medicines Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.